"Multiple sclerosis plus": Frontiers between multiple sclerosis and a new nosological entity;«Sclérose en plaques plus»: Les leucoencéphalopathies aux frontières de la médecine interne

Revue de Medecine Interne

Volumn 21, Issue 12, 2000, Pages 1104-1113

  Pelletier, J ^a,b   Ali Cherif A ^a,b  

^a TIMONE HOSPITAL   (France)

^b INSERM   (France)

Author keywords

Antinuclear antibody; Antiphospholipid antibody; Autoimmunity; Multiple sclerosis

Indexed keywords

ANTINUCLEAR ANTIBODY; BETA INTERFERON; PHOSPHOLIPID ANTIBODY;

AUTOIMMUNITY; CLINICAL FEATURE; DISEASE COURSE; HUMAN; IMMUNOMODULATION; IMMUNOREGULATION; LABORATORY DIAGNOSIS; MULTIPLE SCLEROSIS; PATHOGENESIS; REVIEW; BEHCET DISEASE; DEMYELINATING DISEASE; IMMUNOLOGY; PATHOPHYSIOLOGY;

BEHCET SYNDROME; DEMYELINATING AUTOIMMUNE DISEASES, CNS; HUMANS; MULTIPLE SCLEROSIS;

EID: 0034352482     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0248-8663(00)00270-8     Document Type: Note

References (76)

1. Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis
2. Evidence for genetic basis of multiple sclerosis
3. Multiple sclerosis: B- and T-cell responses to the extracellular domain of the myelin oligodendrocyte glycoprotein
4. Immunomodulation in multiple sclerosis and cytokine response
5. Multiple sclerosis: A coordinated immunological attack against myelin in the central nervous system
6. HLA class II associated genetic susceptibility in multiple sclerosis: A critical evaluation
7. The pathology of multiple sclerosis
8. Multiple sclerosis: Therapeutic update
9. In healthy primates, circulating autoreactive T-cells mediate autoimmune disease
10. Molecular mimicry in T-cell mediated autoimmunity: Viral peptides activates human T-cell clones specific for myelin basic protein
11. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: A comparative study
12. Clinical and laboratory features of primary and secondary progressive MS
13. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
14. Clinical patterns of neurological involvement in Behçet's disease: Evaluation of 200 patients
15. Neurological complications in Behçet's syndrome
16. Behçet's disease and the nervous system
17. Masked assessment of MRI findings: Is it possible to differentiate neuro-Behçet's disease from other central nervous system diseases ?
18. Long-term MR follow-up of cerebral lesions in neuro-Behçet's disease
19. MRI in 31 patients with Behçet's disease and neurological involvement: A prospective study with clinical correlation
20. The place of Behçet's syndrome among the autoimmune diseases
21. The role of heat shock protein, microbial and autoimmune agents with the aetiology of Behçet's disease
22. Systemic lupus erythematosus presenting with neurological disorders
23. Oligoclonal banding of IgG in CSF, blood-brain barrier function, and MRI findings in patients with sarcoidosis, systemic lupus erythematosus, and Behçet's disease involving the nervous system
24. Gadolinium-enhanced magnetic resonance imaging of the central nervous system in systemic lupus erythematosus
25. Tranverse myelitis as a first manifestation of sytemic lupus erythematosus: A case report
26. Lupus-related myelopathy: Report of three cases and review of the literature
27. A case of neuromyelitis optica (Devic's syndrome) in systemic lupus erythematosus: Clinicopathological report and review of the literature
28. Devic's syndrome and systemic lupus erythematosus: A case report with necropsy
29. Cerebrospinal fluid and MRI findings in three patients with multiple sclerosis and systemic lupus erythematosus
30. Devic's neuromyelitis optica during pregnancy in a patient with systemic lupus erythematosus
31. Multiple sclerosis and other immunologic diseases
32. MS and SLE in twins of successive generations
33. Multiple sclerosis and systemic lupus erythematosus. Occurrence in two generations of the same family
34. Neurosarcoidosis: Signs, course and treatment in 35 confirmed cases
35. Central nervous system sarcoidosis: Diagnosis and management
36. Spinal cord granulomatous vasculitis: An unusual clinical presentation of sarcoidosis
37. MR of sarcoidosis in the head and spine: Spectrum of manisfestations and radiographic response to steroid therapy
38. Primary Sjögren's syndrome with central nervous system disease mimicking multiple sclerosis
39. Cerebral white matter lesions in primary Sjögren's syndrome: A controlled study
40. Optic neuropathy and central nervous system disease associated with primary Sjögren's syndrome
41. Neurological manifestations of primary Goujerot-Sjögren syndrome
42. Sjögren's syndrome in patients with multiple sclerosis
43. Prevalence of primary Sjögren's syndrome in patients with multiple sclerosis
44. The prevalence of primary Sjögren syndrome in a multiple sclerosis population
45. Primary Sjögren's syndrome in patients with multiple sclerosis
46. An association between multiple sclerosis and type I diabetes mellitus
47. Multiple sclerosis and Hashimoto's thyroiditis
48. Diseases that mimic multiple sclerosis
49. Multiple sclerosis and autoimmune diseases
50. Myasthenia gravis associated with multiple sclerosis. Epidemiological survey and immunological findings
51. Autoimmunity in multiple sclerosis
52. Association of MS with thyroid disorders
53. Multiple sclerosis and chronic inflammatory diseases. A case-control study
54. Frequency of antinuclear antibodies in multiple sclerosis
55. Antinuclear antibodies in multiple sclerosis
56. Antinuclear antibodies in multiple sclerosis
57. Frequency and significance of antinuclear antibodies in multiple sclerosis
58. Lupoid sclerosis with raised anticardiolipin antibodies
59. Lupoid sclerosis with antiphospholipid and antimyelin antibodies
60. Antiphospholipid antibody syndrome mimicking multiple sclerosis clinically and by magnetic resonance imaging
61. Anticardiolipin antibobies in Japanese patients with multiple sclerosis
62. Visual function in patients with optic neuritis associated with acute transverse myelopathy in multiple sclerosis
63. The epidemiology of multiple sclerosis: A general overview
64. A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: Do they represent a new nosological entity ?
65. Manifestations neurologiques du syndrome des antiphospholipides
66. Anti-phospholipid antibodies in patients with multiple sclerosis and MS-like illnesses: MS or APS ?
67. Systemic autoimmune features and multiple sclerosis
68. Disease-modifying drugs for relapsing-remitting multiple sclerosis and future directions for multiple sclerosis therapeutics
69. No increase of serum autoantibodies during therapy with recombinant human interferon-beta 1a in relapsing-remitting multiple sclerosis
70. No evidence for increased frequency of autoantibodies during interferon beta 1b treatment of multiple sclerosis
71. Autoimmune events during interferon beta-1b treatment for multiple sclerosis
72. Subacute thyroiditis in a patient with MS treated with interferon beta-1a
73. Onset of myasthenia gravis in a patient with multiple sclerosis during interferon beta-1b treatment
74. Severe Raynaud's phenomenon associated with interferon beta treatment for multiple sclerosis
75. Subacute cutaneous lupus erythematosus associated with interferon beta-1a
76. Autoimmune hyperthyroidism in patients with multiple sclerosis treated with interferon beta-1b